<DOC>
	<DOCNO>NCT02573610</DOCNO>
	<brief_summary>The purpose study evaluate superior efficacy DE-108 ophthalmic solution Levofloxacin 0.5 % ophthalmic solution well safety former use perioperative bacteria eradication patient schedule cataract surgery .</brief_summary>
	<brief_title>Study DE-108 Ophthalmic Solution Patients Who Are Scheduled Cataract Surgery</brief_title>
	<detailed_description />
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Those schedule cataract surgery Those suspect ocular infection base clinical finding study eye . Those eye disease cataract require treatment target eye . Those history allergy drug use clinical study ( fluoroquinolones , topical anesthetic povidon iodine ) Those need wear contact lenses study period</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>